4.6 Article

The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Identification of Potent Reverse Indazole Inhibitors for HPK1

Elsie C. Yu et al.

Summary: The study optimized the structure of kinase inhibitor 4 through a systematic two-dimensional diversity screen of pyrazolopyridines, identifying potent and selective compounds. Further optimization led to the identification of potent and selective reverse indazole inhibitor 36 that exhibited low clearance and notable bioavailability in in vivo rat studies, inhibiting phosphorylation of adaptor protein SLP76 in human PBMC.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1

Andrew P. Degnan et al.

Summary: The study presents a novel HPK1 inhibitor which, when used in combination in a colorectal cancer model, significantly enhances the efficacy of anti-PD1 treatment.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds

Brandon A. Vara et al.

Summary: HPK1 is a negative immune regulator primarily expressed in hematopoietic cells, and its loss can enhance T cell signaling and cytokine production, leading to tumor growth inhibition in vivo. The structurally enabled discovery of novel, potent, and selective HPK1 inhibitors, with a carboxamide moiety crucial for enhanced potency and selectivity, holds promise as an immunotherapeutic target.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Biochemistry & Molecular Biology

Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer

Ping Wu et al.

STRUCTURE (2019)

Article Biochemistry & Molecular Biology

Germinal-center kinase-like kinase co-crystal structure reveals a swapped activation loop and C-terminal extension

Douglas Marcotte et al.

PROTEIN SCIENCE (2017)

Article Multidisciplinary Sciences

The target landscape of clinical kinase drugs

Susan Klaeger et al.

SCIENCE (2017)

Article Biochemistry & Molecular Biology

Domain-Swapping Switch Point in Ste20 Protein Kinase SPAK

Clinton A. Taylor et al.

BIOCHEMISTRY (2015)

Article Biochemical Research Methods

Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling

Guillaume Medard et al.

JOURNAL OF PROTEOME RESEARCH (2015)

Article Biotechnology & Applied Microbiology

Big opportunities for small molecules in immuno-oncology

Jerry L. Adams et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Multidisciplinary Sciences

HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance

Huai-Chia Chuang et al.

NATURE COMMUNICATIONS (2014)

Article Immunology

HPK1 as a novel target for cancer immunotherapy

Sansana Sawasdikosol et al.

IMMUNOLOGIC RESEARCH (2012)

Article Biochemical Research Methods

Data processing and analysis with the autoPROC toolbox

Clemens Vonrhein et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemistry & Molecular Biology

Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway

Sansana Sawasdikosol et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Chemistry, Multidisciplinary

Substrate and docking interactions in serine/threonine protein kinases

Elizabeth J. Goldsmith et al.

CHEMICAL REVIEWS (2007)

Article Biotechnology & Applied Microbiology

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Marcus Bantscheff et al.

NATURE BIOTECHNOLOGY (2007)

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

Article Biochemistry & Molecular Biology

Functional interactions of HPK1 with adaptor proteins

JS Boomer et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2005)

Article Hematology

Hematopoietic progenitor kinase 1 supports apoptosis of T lymphocytes

J Schulze-Luehrmann et al.

BLOOD (2002)

Article Biochemistry & Molecular Biology

Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling

P Ling et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)